Drug Type Prophylactic vaccine, Genetically engineered subunit vaccine |
Synonyms Adjuvanted coronavirus vaccine, MCV COVID-19 vaccine, Medigen COVID-19 vaccine |
Target |
Mechanism SARS-CoV-2 S protein inhibitors(Coronavirus spike glycoprotein inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date TW (17 Jul 2021), |
RegulationEmergency Use Authorization (PY) |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
COVID-19 | TW | 17 Jul 2021 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
COVID-19 | Phase 3 | PY | 08 Oct 2021 | |
Severe Acute Respiratory Syndrome | Phase 3 | VN | 30 Dec 2020 | |
Severe Acute Respiratory Syndrome | Phase 3 | TW | 30 Dec 2020 |